vs
Side-by-side financial comparison of Mama's Creations, Inc. (MAMA) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
Vanda Pharmaceuticals Inc. is the larger business by last-quarter revenue ($57.2M vs $47.3M, roughly 1.2× Mama's Creations, Inc.). Mama's Creations, Inc. runs the higher net margin — 1.1% vs -246.8%, a 247.9% gap on every dollar of revenue. On growth, Mama's Creations, Inc. posted the faster year-over-year revenue change (50.0% vs 7.6%). Mama's Creations, Inc. produced more free cash flow last quarter ($3.7M vs $-29.5M). Over the past eight quarters, Mama's Creations, Inc.'s revenue compounded faster (33.0% CAGR vs 9.8%).
Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
MAMA vs VNDA — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $47.3M | $57.2M |
| Net Profit | $540.0K | $-141.2M |
| Gross Margin | 23.6% | — |
| Operating Margin | 1.7% | -70.5% |
| Net Margin | 1.1% | -246.8% |
| Revenue YoY | 50.0% | 7.6% |
| Net Profit YoY | 31.7% | -2774.3% |
| EPS (diluted) | $0.01 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.3M | $57.2M | ||
| Q3 25 | $35.2M | $56.3M | ||
| Q2 25 | $35.3M | $52.6M | ||
| Q1 25 | $33.6M | $50.0M | ||
| Q4 24 | $31.5M | $53.2M | ||
| Q3 24 | $28.4M | $47.7M | ||
| Q2 24 | $29.8M | $50.5M | ||
| Q1 24 | $26.7M | $47.5M |
| Q4 25 | $540.0K | $-141.2M | ||
| Q3 25 | $1.3M | $-22.6M | ||
| Q2 25 | $1.2M | $-27.2M | ||
| Q1 25 | $1.6M | $-29.5M | ||
| Q4 24 | $410.0K | $-4.9M | ||
| Q3 24 | $1.1M | $-5.3M | ||
| Q2 24 | $553.0K | $-4.5M | ||
| Q1 24 | $1.4M | $-4.1M |
| Q4 25 | 23.6% | — | ||
| Q3 25 | 24.9% | — | ||
| Q2 25 | 26.1% | — | ||
| Q1 25 | 27.0% | — | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 24.2% | — | ||
| Q2 24 | 25.0% | — | ||
| Q1 24 | 29.3% | — |
| Q4 25 | 1.7% | -70.5% | ||
| Q3 25 | 4.8% | -55.6% | ||
| Q2 25 | 4.5% | -73.2% | ||
| Q1 25 | 5.7% | -82.0% | ||
| Q4 24 | 1.8% | -19.3% | ||
| Q3 24 | 5.7% | -23.1% | ||
| Q2 24 | 2.6% | -20.1% | ||
| Q1 24 | 7.4% | -19.5% |
| Q4 25 | 1.1% | -246.8% | ||
| Q3 25 | 3.6% | -40.1% | ||
| Q2 25 | 3.5% | -51.7% | ||
| Q1 25 | 4.8% | -58.9% | ||
| Q4 24 | 1.3% | -9.2% | ||
| Q3 24 | 4.0% | -11.2% | ||
| Q2 24 | 1.9% | -9.0% | ||
| Q1 24 | 5.3% | -8.7% |
| Q4 25 | $0.01 | $-2.40 | ||
| Q3 25 | $0.03 | $-0.38 | ||
| Q2 25 | $0.03 | $-0.46 | ||
| Q1 25 | $0.04 | $-0.50 | ||
| Q4 24 | $0.01 | $-0.09 | ||
| Q3 24 | $0.03 | $-0.09 | ||
| Q2 24 | $0.01 | $-0.08 | ||
| Q1 24 | $0.03 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.1M | $84.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $49.6M | $327.2M |
| Total Assets | $84.0M | $488.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.1M | $84.9M | ||
| Q3 25 | $9.4M | $70.0M | ||
| Q2 25 | $12.0M | $81.0M | ||
| Q1 25 | $7.2M | $111.8M | ||
| Q4 24 | $9.3M | $102.3M | ||
| Q3 24 | $7.4M | $100.5M | ||
| Q2 24 | $13.0M | $103.0M | ||
| Q1 24 | $11.0M | $125.2M |
| Q4 25 | $49.6M | $327.2M | ||
| Q3 25 | $29.6M | $466.0M | ||
| Q2 25 | $26.4M | $486.3M | ||
| Q1 25 | $24.9M | $511.4M | ||
| Q4 24 | $23.0M | $538.5M | ||
| Q3 24 | $22.3M | $541.2M | ||
| Q2 24 | $20.3M | $542.5M | ||
| Q1 24 | $19.6M | $544.0M |
| Q4 25 | $84.0M | $488.9M | ||
| Q3 25 | $51.2M | $601.1M | ||
| Q2 25 | $52.7M | $624.7M | ||
| Q1 25 | $47.1M | $631.9M | ||
| Q4 24 | $47.9M | $656.2M | ||
| Q3 24 | $43.0M | $645.1M | ||
| Q2 24 | $47.2M | $651.4M | ||
| Q1 24 | $45.1M | $652.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $3.9M | $-29.4M |
| Free Cash FlowOCF − Capex | $3.7M | $-29.5M |
| FCF MarginFCF / Revenue | 7.8% | -51.6% |
| Capex IntensityCapex / Revenue | 0.4% | 0.2% |
| Cash ConversionOCF / Net Profit | 7.16× | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.0M | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.9M | $-29.4M | ||
| Q3 25 | $-1.7M | $-31.6M | ||
| Q2 25 | $6.0M | $-15.3M | ||
| Q1 25 | $-857.0K | $-33.1M | ||
| Q4 24 | $4.8M | $-1.8M | ||
| Q3 24 | $-2.4M | $-14.6M | ||
| Q2 24 | $3.6M | $-6.9M | ||
| Q1 24 | $6.7M | $7.6M |
| Q4 25 | $3.7M | $-29.5M | ||
| Q3 25 | $-2.2M | $-31.8M | ||
| Q2 25 | $5.5M | $-15.6M | ||
| Q1 25 | $-930.0K | $-33.6M | ||
| Q4 24 | $2.5M | $-2.0M | ||
| Q3 24 | $-4.0M | $-14.7M | ||
| Q2 24 | $2.5M | $-7.0M | ||
| Q1 24 | $6.6M | $7.6M |
| Q4 25 | 7.8% | -51.6% | ||
| Q3 25 | -6.2% | -56.5% | ||
| Q2 25 | 15.5% | -29.6% | ||
| Q1 25 | -2.8% | -67.1% | ||
| Q4 24 | 8.0% | -3.8% | ||
| Q3 24 | -14.1% | -30.9% | ||
| Q2 24 | 8.4% | -13.9% | ||
| Q1 24 | 24.8% | 15.9% |
| Q4 25 | 0.4% | 0.2% | ||
| Q3 25 | 1.5% | 0.3% | ||
| Q2 25 | 1.5% | 0.6% | ||
| Q1 25 | 0.2% | 0.9% | ||
| Q4 24 | 7.2% | 0.4% | ||
| Q3 24 | 5.6% | 0.3% | ||
| Q2 24 | 3.8% | 0.2% | ||
| Q1 24 | 0.4% | 0.0% |
| Q4 25 | 7.16× | — | ||
| Q3 25 | -1.31× | — | ||
| Q2 25 | 4.85× | — | ||
| Q1 25 | -0.54× | — | ||
| Q4 24 | 11.71× | — | ||
| Q3 24 | -2.10× | — | ||
| Q2 24 | 6.58× | — | ||
| Q1 24 | 4.79× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MAMA
Segment breakdown not available.
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |